Tricida, Inc. (NASDAQ:TCDA – Get Rating) major shareholder Venrock Healthcare Capital Par purchased 61,722 shares of Tricida stock in a transaction dated Thursday, June 2nd. The shares were purchased at an average price of $8.78 per share, with a total value of $541,919.16. Following the completion of the acquisition, the insider now owns 5,736,011 shares […]
The Goldman Sachs Group initiated coverage on shares of Tricida (NASDAQ:TCDA – Get Rating) in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage set a “buy” rating on the stock. Several other equities research analysts have also recently commented on TCDA. Zacks Investment Research cut Tricida from a […]
Tricida (NASDAQ:TCDA – Get Rating)‘s stock had its “buy” rating reaffirmed by research analysts at Needham & Company LLC in a report released on Wednesday, Benzinga reports. They currently have a $18.00 price target on the stock, down from their previous price target of $20.00. Needham & Company LLC’s target price points to a potential […]
Two Sigma Investments LP decreased its holdings in shares of Tricida, Inc. (NASDAQ:TCDA – Get Rating) by 66.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 136,324 shares of the company’s stock after selling 271,893 shares during the period. Two Sigma Investments LP owned approximately […]